Dr Sophie Morgan is an associate editor for the Neuroscience and Psychology team at Nature Communications. She received her PhD in molecular neuroscience from the MRC Laboratory of Molecular Biology, where she studied α-synuclein aggregation and propagation. As a postdoctoral researcher at the Oxford Drug Discovery Institute, Sophie designed cellular assays for novel Parkinson’s disease drug targets. At Nature Communications Sophie handles submissions on neurodegeneration and neurological diseases.
